Even though prices have improved a little in recent days, risk still exists for a deeper decline for SPLK.
Following its Aetna acquisition that closed back in November, CVS is positioning itself for further strength.
We reviewed 40 stocks that are in the business of water -- only these 4 are considered buys.
What is obvious is that President Trump is growing concerned about the economic impact on the tariffs.
What's driving the stock's recent fall from grace with investors?
Our latest analysis and strategy on these FAANG shares.
We run Medical Properties Trust through our dividend-metric gauntlet to see whether the healthcare REIT can maintain its payout pace.
CVS continues to move in the right direction for the bulls.
There has been a lot of sideways action in the company's shares since it went public last spring and that pattern could continue in the weeks ahead.
The bond market is running the show? The answer would be... as much if not more than anything else... again.